In lung cancer samples, after 15 days of culture, the number of CD8+ T lymphocytes increased 405 (108–2510)-fold to 3313.0 ± 2382.5 × 106 cells, with a cell viability of 97.6% and frequency of 68.7 ± 14.9%. This evidence concerns the gene CD8A and lung carcinoma.